Nik Wallenda, first man to complete 1800-feet tightrope walk across Niagara Falls

June 16, 2012

niagara_falla_tightrope_walk.295

Ontario, Canada, June 16: Daredevil Nik Wallenda became the first person to walk on a tightrope across the Niagara Falls, taking steady, measured steps Friday night for 1,800 feet across the mist-fogged brink of the roaring falls separating the U.S. and Canada.

"I feel like I'm on cloud nine right now," an exuberant Wallenda told reporters after accomplishing what he said was his childhood dream before an estimated 112,000 people crowding the shores of both countries and millions more who watched a live television broadcast.

He described wind "coming from every which way," mist so powerful he had to blink it away to maintain his vision and a breathtaking view during the nighttime walk illuminated by spotlights that "compared to nothing."

"There was no way to focus on the movement of the cable," said Wallenda, 33. "If I looked down at the cable there was water moving everywhere. And if I looked up there was heavy mist blowing in front of my face. So it was a very unique, a weird sensation."

He said he accomplished the feat through "a lot of praying, that's for sure. But, you know, it's all about the concentration, the focus, and the training."

The seventh-generation member of the famed Flying Wallendas had long dreamed of pulling off the stunt, never before attempted. Other daredevils have wire-walked over the Niagara River but farther downstream and not since 1896.


"This is what dreams are made of, people," said Wallenda, who wore a microphone for the broadcast, shortly after he stepped off from a platform on the American shore.

Along the way, he calmly prayed aloud.

After passing the halfway mark, Wallenda expressed fatigue. "I'm strained, I'm drained," he said. "This is so physical, not only mental but physical."

Toward the end, as he neared the Canadian shore, Wallenda dropped to one knee and pumped his fist while the spectators cheered.


He broke into a playful run about 15 feet from the finish line, where his wife and three children waited.

"I am so blessed," he said later. "How blessed I am to have the life that I have."

ABC televised the walk and insisted Wallenda use a tether to keep him from falling in the river. Wallenda said he agreed because he wasn't willing to lose the chance to perform the walk it took him well over a year to win permission from two countries to do. Such stunts are normally illegal. ABC's sponsorship helped offset some of the $1.3 million cost of the spectacle.

Wallenda said he thought about the tether, which was secured at his waist and dragged behind him, at several points along the 30-minute walk but wasn't hindered by it as he'd feared.

"Awesome! The whole thing is awesome," 8-year-old William Clements of Dresden, Ontario, said after watching the walk with his family from the Canadian side, adding he wouldn't want to walk "even over something not high."

"He was meant to do it. The weather was perfect," said Glenda Rutherford of Ontario. "It was amazing."

For Wallenda, who has grown up on the high wire and holds six Guinness records for various stunts, the Niagara Falls walk was unlike anything he'd ever done. Because it was over water, the 2-inch wire didn't have the usual stabilizer cables to keep it from swinging. Pendulum anchors were designed to keep it from twisting under the elkskin-soled shoes designed by his mother.

The Wallendas trace their roots to 1780 Austria-Hungary, when ancestors traveled as a band of acrobats, aerialists, jugglers, animal trainers and trapeze artists. The clan has been touched by tragedy, notably in 1978 when patriarch Karl Wallenda, Nik's great-grandfather, fell to his death during a stunt in Puerto Rico.

Wallenda said that at one point in the middle of the walk, he thought about his great-grandfather and the walks he had taken:


"That's what this is all about, paying tribute to my ancestors, and my hero, Karl Wallenda."

About a dozen other tightrope artists have crossed the Niagara Gorge downstream, dating to Jean Francois Gravelet, aka The Great Blondin, in 1859. But no one had walked directly over the falls, and authorities hadn't allowed any tightrope acts in the area since 1896. It took Wallenda two years to persuade U.S. and Canadian authorities to allow it, and many civic leaders hoped to use the publicity to jumpstart the region's struggling economy, particularly on the U.S. side of the falls.




Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Beijing, Mar 25: Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Y UDAYA CHANDAR
 - 
Monday, 13 Apr 2020

Dear Sir,

 

I am 77 but a very healthy person with remarkable immunity. I contracted Malaria fever in 1994 because of mosquito biting and I have not been sick anytime there after, not even for ordinary fever in the last 26 years.

 

I am sure you would like to conduct the trials on persons of varying criteria. I am sure you don't want to carry out the trials on perfectly healthy young individuals only. 

 

I am certain that  you want to try the vaccine on a 'common man' from 'general public.' I am ready for the trial and you can take me. I will be delighted. 

 

If you are not handling this matter kindly forward this mail to the correct agency.

 

I look forward to hearing from you.

 

Best regards.

 

If you are not moving forward, you are really moving backward.

Y Udaya Chandar

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 25,2020

Beijing:  Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 17,2020

Beijing, Jun 17: China said Wednesday it wanted to avoid further clashes with India along their border after the first deadly confrontation between the two nuclear powers in decades.

The two countries have traded blame for Monday's high-altitude brawl that left at least 20 Indian soldiers dead, with China refusing to confirm so far whether there were any casualties on its side.

Chinese foreign ministry spokesman Zhao Lijian insisted again Wednesday that it was Indian troops who illegally crossed the border and attacked the Chinese side.

This led to "a serious physical confrontation between both sides that caused deaths and injuries", Zhao said at a regular briefing, without providing more details about the casualties.

He said China urges India to "strictly restrain frontline troops, do not illegally cross the border, do not make provocative gestures, do not take any unilateral actions that will complicate the border situation".

But he added that the two sides "will continue to resolve this issue through dialogue and negotiations".

"We of course don't wish to see more clashes," Zhao said.

Comments

Indian baba
 - 
Wednesday, 17 Jun 2020

we have 56 inch chest man as our leader...he alone will fight the war and give victory to india..jai bakth

 

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.